Who and when should we screen for prostate cancer? Interviews with key opinion leaders

Sigrid Carlsson, Michael Leapman , Peter Carroll, Fritz H Schroder, Peter Albertsen, Dragan Ilic, Michael J Barry, Dominick Frosch, Andrew Vickers

Research output: Contribution to journalArticleOtherpeer-review

8 Citations (Scopus)


Prostate cancer screening using prostate-specific antigen (PSA) is highly controversial. In this Q & A, Guest Editors for BMC Medicine’s ‘Spotlight on Prostate Cancer’ article collection, Sigrid Carlsson and Andrew Vickers, invite some of the world’s key opinion leaders to discuss who, and when, to screen for prostate cancer. In response to the points of view from the invited experts, the Guest Editors summarize the experts’ views and give their own personal opinions on PSA screening.
Original languageEnglish
Article number288
JournalBMC Medicine
Publication statusPublished - 27 Nov 2015

Cite this